Adjust Text Size:
Browse Clinical Trials
Join the Email List
Sign up for our email bulletin
Participant Stories
“I participate because it is the right thing to do, for myself, for my children, and for the millions of people who have Parkinson’s disease. Without participation there will be no cure.” –Mike, Diagnosed 7 years
Recently Diagnosed with Parkinson's Disease?
If you have recently been diagnosed with Parkinson’s disease (PD) understanding the disease, and learning about the resources available to you, are good first steps.
Study of the Brains of People with Inherited Parkinson's Disease
Official Study Title: PET Scanning in Parkinson's Disease
Sponsor: National Human Genome Research Institute National Human Genome Research Institute (NHGRI)A branch of the National Institutes of Health (NIH) that deals with genetic research. Internet address: http://www.genome.gov
(NHGRI)
Clinicaltrials.gov ID: NCT00024622
Study ID: NCT00024622
Summary
This study uses advanced imaging to learn what is unique about the brains of people who have inherited Parkinson's disease. Parkinson's DiseaseA chronic, slowly progressive disease of the nervous system characterized by the combination of tremor, rigidity, bradykinesia and stooped posture, among other symptoms. This trial will study chemical activity and blood flow in the brain of a person that has Parkinson's disease, together with their family members who do not have the disease. Participants in this trial will undergo 2 types of advanced imaging of the brain (Magnetic Resonance Imaging Magnetic Resonance Imaging (MRI)A non-invasive technique that uses magnetism to create detailed pictures of the inside of the human body. or MRI and Positron Emission Tomography or PET scan). This trial does not treat the symptoms of Parkinson's disease.
Study Phase
Not Applicable
What is a study phase?
Symptoms Addressed: Study does not address symptoms
Study does not address symptoms
Time Commitment
- Less than one day
- one office visit
Eligibility
- Minimum Age: 18
- Gender(s) Accepted: Either
- Study is enrolling non-PD participants
Inclusion Criteria
- Age 18 or older
- This trial accepts people with Parkinson's disease
- This trial accepts healthy volunteers
Enrollment
Expected Enrollment: 400 (US)
Date Enrollment Began: Sep 2002
Date Enrollment Ends: Sep 2002
Last Updated Date: Sep 25 2008
Trial Post Date: Jul 20 2004
Website: http://clinicaltrials.gov/show/NCT00024622
Primary Contacts and Locations
Maryland
- Joie Davis — Trial Coordinator
National Human Genome Research Institute
Phone: 301-435-6691
9000 Rockville Pike
Bethesda, MD 20892
USA
Local Contacts and Locations
Maryland
- Ellen Sidransky — Trial Coordinator
National Human Genome Research Institute
Phone: 301-496-0373
9000 Rockville Pike
Bethesda, MD 20892
USA
